Drug recall · January 3, 2018
Auryxia recall
Why: Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Auryxia (ferric citrate) tablets, 210 mg , 200-count bottles, RX ONLY, Manufactured for and distributed by: Keryx Biopharmaceticals, Inc. One Marina Park Drive, 12th Floor, Boston, MA 02210 USA. NDC 59922-631-01
- Lots / codes
Lot # AH3842
- Quantity
- 2,488 200-bottles
- Company
- Keryx Biopharmaceuticals, Inc., Boston, MA
- Distribution
- Distributed nationwide in the USA
- Initiated
- December 12, 2017 · Voluntary: Firm initiated
- Classified
- December 26, 2017
- Reported
- January 3, 2018
- Ended
- October 1, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Auryxia
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.